CareDx (CDNA) has been beaten down lately with too much selling pressure. While the stock has lost 22.5% over the past four weeks, there is light at the end of the tunnel as it is now in oversold ...

Fred Alger Management, an investment management company, released its “Alger Small Cap Growth Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. U.S. equities rose ...

AMD's next-gen CDNA 3 architecture will be the first exascale APU design, packing both CPU and GPU chiplets on the same package. AMD has promised an insane 5x or higher (AI) performance-per-watt ...

AMD gave us a glimpse of its future this week, divulging new information about its Radeon and Ryzen roadmaps during the company’s Financial Analyst Day. Lots of new information was disseminated, but ...

In a unanimous decision last month, the Supreme Court ruled that naturally occurring genes are not patentable. But, said the Court, cDNA, a man-made copy of the genetic messenger in cells, is ...

Investors in CareDx Inc (Symbol: CDNA) saw new options begin trading this week, for the February 2026 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is ...

Back in 2020, AMD announced it was splitting its post-GCN architecture into RDNA for gaming, with CDNA for its data center GPUs, with CDNA later being the architecture of its Radeon Instinct AI ...

Using the normalized data from our 9930 clone cDNA microarrays, gene lists were generated by SAM (version 1.12) for differentially expressed genes in the comparisons between C3.6 (moderately ...

AMD has revealed plans to integrate its current RDNA and CDNA architectures into a unified system called UDNA. This move is part of the company's broader strategy to strengthen its position in the ...

Although qRT-PCR studies provide valuable information about the relative expression of transcripts in a cell, they are difficult to perform with very small numbers of cells (for example, 1–1,000 cells ...